When Safety Becomes the Risk

Capital moved into defensives this month. Energy, materials, and consumer staples led sector gains through January 23, 2026. Utilities posted back-to-back years of double-digit returns. The rotation is real. But does it reflect true safety? Or is this late-stage crowding that turns protection into risk?

I watch markets like a machine watches inputs. Right now, the inputs conflict. Consumer staples lagged the S&P 500 through 2025. Investors chased AI-driven growth instead. That gap created value in some names. In others, it hides real damage dressed up as discount.

Price is pressure. Pressure reveals what stories cannot.

Consumer staples stocks lagged in 2025. The sector fell 0.8%. That made it the worst performer of the year. Fidelity notes three headwinds: AI growth stole focus, GLP-1 drugs shifted buying habits, and inflation squeezed margins.

Here is what matters. History shows staples gain 17.1% on average the year after they lag. Cabot Wealth flagged this pattern. It points to rebound potential in 2026.

But rebounds are not certain. Schwab rates staples as marketperform. They cite margin pressure from inflation. Companies lack pricing power. Tariff hikes could add more strain. The sector holds up in downturns. Whether it holds margins now remains unclear.

The discount is real. The question is whether the business case supports it.

Fidelity names stocks that fell hard in 2025. Mondelez and Keurig Dr Pepper look cheap next to AI premiums. Energizer trades as if broken for good. These are not failed companies. They are priced for decline that may never come.

The One Big Beautiful Bill Act adds fiscal stimulus. It should boost middle-income spending. That tailwind could ease the inflation that hurt staples margins in 2025. Constellation Brands and Diageo faced GLP-1 and youth trend headwinds. Stimulus flows may help them stabilize.

Utilities rose 23.4% in 2024. They added 13% in 2025. Two years of gains totaling 36%. That is not defense. That is momentum.

Schwab rates utilities as underperform. Valuations ran too high. Rising Treasury yields threaten dividend appeal. When the 10-year offers solid yield with less risk, utility premiums shrink.

Yet the growth story holds. Fidelity sees years of gains ahead from data centers, onshoring, and electrification. AI power demand alone marks a major shift. Electric utilities sit at the heart of this change.

The tension is clear: structural tailwinds versus stretched prices.

This is where discipline matters. Buying utilities in 2024 captured the thesis early. Buying in January 2026 means paying up for growth already priced in.

NerdWallet notes that staples like food and medicine show inflation resistance. People buy essentials no matter what. Utilities share this trait. People need power. They need medicine. They need food. But need does not set price. Valuation sets return.

Not all defensive names carry the same risk. The spread within sectors creates chances for those who dig deeper.

Fidelity highlights Kenvue, the Tylenol maker. It trades cheap amid safety claims and possible Kimberly-Clark interest. The market priced in the worst. If that worst fails to arrive, the stock could rerate sharply.

Target offers another case. The retailer lost ground to Walmart in 2025. Share loss is real. But the price now reflects that loss and more. The question: does Target stabilize or keep bleeding? Fiscal stimulus for middle earners could spark a turn.

These are not momentum trades. They need patience and conviction.

Alcohol names like Diageo faced three headwinds in 2025. GLP-1 drugs cut drinking. Youth trends shifted. The economy pressed down. Fidelity argues investors overstated how long these last. Global brands with stimulus exposure may fare better in 2026.

Independent Trust data shows staples leading early 2026 gains. This backs the rotation thesis. Capital is moving. The skill lies in knowing whether that capital chases or leads.

Markets often delay risk pricing until the threat becomes obvious. Defensive sectors draw capital when growth slows and doubt rises. That draw makes sense. But execution decides whether it protects or destroys value.

Here is what the data shows:

Consumer staples hold real value in select names. Some fell more than their business did. Mondelez, Keurig Dr Pepper, and Energizer could rebound with fiscal tailwinds. Avoid names with weak margins and no pricing power.

Utilities face price risk after 36% two-year gains. Growth from AI and electrification is real. But Schwab's underperform rating flags the tension. Entry price matters more than thesis strength when values stretch.

Dividend aristocrats need stock-by-stock review. The label alone does not mean safety. Business model, market position, and price decide protection.

The rotation into defensives is not wrong. It is incomplete. Capital flowing into a sector does not make it safe. It makes it crowded. Crowded trades unwind when the story shifts.

Hard assets do not chase stories. Neither should your capital.

The doctrine: defensive positioning is not a sector bet. It is a discipline. Buy businesses priced for decline that will not happen. Avoid businesses priced for growth already captured. Let valuation, not momentum, guide your entry.

Until next time,

Macro Analyst - Daniel Whitmore